Similar articles for PMID: 21425112

Year	Number of Results
2003	1
2004	2
2006	2
2007	2
2008	7
2009	5
2010	10
2011	6
2012	10
2013	6
2014	14
2015	10
2016	17
2017	8
2018	4
2019	5
2020	2
2021	5
2022	1
2023	3
2024	0

1

[Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view].

Soler B, Fadic R, von Bernhardi R. Soler B, et al. Rev Neurol. 2011 Apr 1;52(7):426-34. Rev Neurol. 2011. PMID: 21425112 Free article. Review. Spanish.

2

Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.

Marconi S, Bonaconsa M, Scambi I, Squintani GM, Rui W, Turano E, Ungaro D, D'Agostino S, Barbieri F, Angiari S, Farinazzo A, Constantin G, Del Carro U, Bonetti B, Mariotti R. Marconi S, et al. Neuroscience. 2013 Sep 17;248:333-43. doi: 10.1016/j.neuroscience.2013.05.034. Epub 2013 May 28. Neuroscience. 2013. PMID: 23727509

3

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.

Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D. Petrou P, et al. JAMA Neurol. 2016 Mar;73(3):337-44. doi: 10.1001/jamaneurol.2015.4321. JAMA Neurol. 2016. PMID: 26751635 Clinical Trial.

4

Transplantation of mesenchymal stem cells in ALS.

Mazzini L, Vercelli A, Ferrero I, Boido M, Cantello R, Fagioli F. Mazzini L, et al. Prog Brain Res. 2012;201:333-59. doi: 10.1016/B978-0-444-59544-7.00016-0. Prog Brain Res. 2012. PMID: 23186722 Free article. Review.

5

Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.

Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, Chang IY, Kim KS, Kim SH. Oh KW, et al. Stem Cells Transl Med. 2015 Jun;4(6):590-7. doi: 10.5966/sctm.2014-0212. Epub 2015 May 1. Stem Cells Transl Med. 2015. PMID: 25934946 Free PMC article. Clinical Trial.

6

Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?

Allers C, Jones JA, Lasala GP, Minguell JJ. Allers C, et al. Regen Med. 2014;9(5):637-47. doi: 10.2217/rme.14.30. Regen Med. 2014. PMID: 25372079 Review.

7

Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.

Chan-Il C, Young-Don L, Heejaung K, Kim SH, Suh-Kim H, Kim SS. Chan-Il C, et al. Cell Transplant. 2013;22(5):855-70. doi: 10.3727/096368912X637019. Cell Transplant. 2013. PMID: 22472631 Free article.

8

Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).

Haidet-Phillips AM, Maragakis NJ. Haidet-Phillips AM, et al. Brain Res. 2015 Dec 2;1628(Pt B):343-350. doi: 10.1016/j.brainres.2015.06.035. Epub 2015 Jul 14. Brain Res. 2015. PMID: 26187754 Free PMC article. Review.

9

Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.

Faravelli I, Riboldi G, Nizzardo M, Simone C, Zanetta C, Bresolin N, Comi GP, Corti S. Faravelli I, et al. Cell Mol Life Sci. 2014 Sep;71(17):3257-68. doi: 10.1007/s00018-014-1613-4. Epub 2014 Apr 4. Cell Mol Life Sci. 2014. PMID: 24699704 Review.

10

Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiation.

Shakhbazau A, Potapnev M. Shakhbazau A, et al. Cytotherapy. 2016 Oct;18(10):1245-55. doi: 10.1016/j.jcyt.2016.06.001. Epub 2016 Jul 12. Cytotherapy. 2016. PMID: 27426933 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year